TruBridge (NASDAQ:TBRG – Get Free Report) and Precipio (NASDAQ:PRPO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.
Volatility & Risk
TruBridge has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current recommendations for TruBridge and Precipio, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TruBridge | 0 | 8 | 0 | 0 | 2.00 |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares TruBridge and Precipio’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TruBridge | 0.92% | 18.75% | 8.32% |
| Precipio | -3.57% | -6.73% | -4.49% |
Earnings & Valuation
This table compares TruBridge and Precipio”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TruBridge | $346.84 million | 1.12 | $4.21 million | $0.20 | 129.85 |
| Precipio | $24.05 million | 1.79 | -$360,000.00 | ($0.47) | -51.15 |
TruBridge has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than TruBridge, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
88.6% of TruBridge shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 10.7% of TruBridge shares are held by company insiders. Comparatively, 16.6% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
TruBridge beats Precipio on 10 of the 13 factors compared between the two stocks.
About TruBridge
TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.
